James Barlow
Vermogen: 136 900 $ op 30-09-2026
Vermogen: 136 900 $ op 30-09-2026
Mr. James F.
Barlow, CPA, is an Independent Director at Arcturus Therapeutics Holdings, Inc., an Independent Director at Arcturus Therapeutics Ltd. and a Vice President at Vicept Therapeutics, Inc. He is on the Board of Directors at Nahs Holding, Inc., Arcturus Therapeutics Holdings, Inc., Arcturus Therapeutics Ltd. and Arcturus Therapeutics, Inc. Mr. Barlow was previously employed as a Chief Accounting Officer, Senior VP & Controller by Allergan, Inc., a Chief Financial Officer by Wynn Oil Co., a Treasurer & Controller by Wynn's International, Inc., a Vice President & Controller by Ford Equipment Leasing Co., and a Principal by Deloitte Haskins & Sells (US).
He received his undergraduate degree from Brigham Young University and a graduate degree from Brigham Young University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-06-2026 | 10.000 ( 0,04% ) | 136 900 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Directeur/Bestuurslid | 27-05-2018 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Corporate Officer/Principal | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Directeur/Bestuurslid | 27-05-2018 |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Directeur/Bestuurslid | - |
Nahs Holding, Inc. | Directeur/Bestuurslid | 01-07-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN, INC. | Comptroller/Controller/Auditor | 01-03-2015 |
Winco Enterprises, Inc.
Winco Enterprises, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and markets automotive & industrial chemical products | Financieel Directeur/CFO | 01-08-2001 |
Wynn's International, Inc.
Wynn's International, Inc. Automotive AftermarketConsumer Durables Supplies automotive, industrial components and specialty chemical products | Comptroller/Controller/Auditor | 01-09-2000 |
Ford Equipment Leasing Co. | Comptroller/Controller/Auditor | 01-01-1990 |
| ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wynn's International, Inc.
Wynn's International, Inc. Automotive AftermarketConsumer Durables Supplies automotive, industrial components and specialty chemical products | Consumer Durables |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Winco Enterprises, Inc.
Winco Enterprises, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures and markets automotive & industrial chemical products | Process Industries |
Ford Equipment Leasing Co. | |
Deloitte Haskins & Sells (US) | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Nahs Holding, Inc. | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau